InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

ICU Stock Earnings: SeaStar Medical Holding Beats EPS for Q2 2024

By InvestorPlace Earnings

ICU stock results show that SeaStar Medical Holding beat analyst estimates for earnings per share the second quarter of 2024.

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

NKTX Stock Earnings: Nkarta Beats EPS for Q2 2024

By InvestorPlace Earnings

NKTX stock results show that Nkarta beat analyst estimates for earnings per share the second quarter of 2024.

ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2024

By InvestorPlace Earnings

ATYR stock results show that aTyr Pharma beat analyst estimates for earnings per share the second quarter of 2024.

Load More